Hypercalcaemia due to sarcoidosis corrects with bisphosphonate treatment

Charles J. Gibbs, Munro Peacock

Research output: Contribution to journalArticle

22 Scopus citations

Abstract

We report a case of sarcoid hypercalcaemia treated with the bisphosphonate, APD 1(3-amino-l-hydroxypropylidene)-1,1-bisphosphonatel. Investigations showed that the hypercalcaemia was associated with a high plasma 1,25 dihydroxy vitamin D concentration. A low dietary intake of calcium partially corrected the hypercalcaemia but APD rapidly nonnalized plasma calcium without reducing the elevated 1,25 dihydroxy vitamin D concentration. The case demonstrates that hypercalcaemia in sarcoidosis results from the effects of 1,25 dihydroxy vitamin D on bone as well as on calcium absorption and that prolonged suppression of the effect on bone occurs with APD treatment.

Original languageEnglish (US)
Pages (from-to)937-938
Number of pages2
JournalPostgraduate Medical Journal
Volume62
Issue number732
DOIs
StatePublished - Jan 1 1986

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this